Resultados de la búsqueda 91-100 of 16705 for hospice

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from injury ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

  5. Transplant Center de Mayo Clinic - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to validate the use of a lymphatic imaging protocol to stage disease severity in patients with lymphedema and serve as a biomarker ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy. A ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...